Research and analysis

Herpes zoster (shingles) immunisation programme 2023 to 2024 [Zostavax庐]: evaluation reports

Evaluation of the eleventh year of the Zostavax庐 shingles vaccination programme in England: financial year 2023 to 2024.

From:
UK Health Security Agency
Published
25 July 2024
Last updated
23 August 2024 鈥� See all updates

Applies to England

Documents

Shingles vaccine coverage (England): report for quarter 2 of the financial year 2023 to 2024

Ref: HPR 18(6)

HTML

Ref: HPR 18(6)

ODS, 208 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage (England): report for quarter 1 of the financial year 2023 to 2024

Ref: HPR 18(6)

HTML

Ref: HPR 18(6)

MS Excel Spreadsheet, 205 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

For previous reports, see聽Herpes zoster (shingles) immunisation programme 2022 to 2023: evaluation reports.

Updates to this page

Published 25 July 2024
Last updated 23 August 2024 show all updates

  1. Added Q2 report of FY 2023/24 (and associated data tables file).

  2. First published.

Sign up for emails or print this page

Related content